This report presents a strategic analysis of the China Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Medical Devices Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Acne Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Insulin Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Skin Antiseptic Products Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Vaccines Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the China Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy and expert insights.
The China Lipid Disorder Therapeutics Market was valued at $262.6 Mn in 2023 and is predicted to grow at a CAGR of 10.63% from 2023 to 2030, to $532.6 Mn by 2030. China Lipid Disorder Therapeutics Market is growing due to Increasing Healthcare Expenditure, Rising Prevalence of Dyslipidemia, and Expanding Treatment Guidelines. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd.Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
The China Hemodialysis Equipment Market was valued at $1135.1 Mn in 2023 and is projected to grow at a CAGR of 9.1% from 2023 to 2023, to $2088.3 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Bain Medical Equipment, Guangdong Biolight Meditech, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Nipro Corp among others.
The China Dental Fluoride Treatment Market was valued at $1219.2 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $1761.9 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Colgate, Amway (China) Co. Ltd, Colgate-Palmolive Co, GlaxoSmithKline plc, Guangxi Aoqili Co. Ltd among others.
The China Financial Assistance Programs Market was valued at $2,278.1 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $6,477.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as CSPC Pharmaceuticals, Cardinal Health, Sinopharm Group Co Ltd, Merck, GSK, Johnson & Johnson, Novartis among others.
The China Cold Pain Therapy Market was valued at $177 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $297 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic pain disorders, technological advances in the industry, and changing consumer preferences. The industry is primarily dominated by players such as Meditech, Beijing Beike, Ossur, Shanghai Olympus, Pfizer, and Hisamitsu among others.
The China Alopecia (Hair Loss) Therapeutics Market was valued at US $0.66 Bn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $1.31 Bn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, technological advancements and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Curollax, Lutronic, Pfizer among others.
The China Periodontal Therapeutics Market was valued at $70.2 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $125.8 Mn by 2030. China Periodontal Therapeutics Market is growing due to Economic Growth and Rising Disposable Income, Technological Advancements, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Chartwell Pharmaceuticals LLC, ASA Dental, Steris-Hu-Friedy, Envista Holding Corporation, and Tokyo Chemical Industry Co. Ltd.
The China Radiology Service Market was valued at $321.6 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $919.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the China Radiology Service Market are Peking Union Medical College Hospital, Shanghai Huashan Hospital, Guangzhou Medical University Affiliated Cancer Hospital, Fudan University Shanghai Cancer Centre, Beijing Cancer Hospital, and Shanghai Renji Hospital, among others.
The China Biobanks Market was valued at $6,168.90 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $12,252.90 Mn by 2030. The key drivers of this industry include government support, rising chronic diseases, and research and development initiatives. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
China Chronic Cough Therapeutics Market was valued at $506 Mn in 2022 and is estimated to reach $1054 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include Hengan Group, Guangzhou Pharmaceutical Holdings, Shanghai Fosun Pharmaceutical, Beijing Tongrentang Group, Merck, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis and GlaxoSmithKline.
The China MRI Market was valued at $533.77 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $914.79 Mn by 2030. The key drivers of this industry include the rise in geriatric population, rising burden of chronic diseases, and technological advancements in MRI. The key players in the industry are GE Healthcare, Koninklijke Philips NV, Shenzhen Basda Medical Apparatus, and United Imaging Healthcare among others.
The China Hypersomnia Therapeutics Market was valued at $59.80 Mn in 2023 and is predicted to grow at a CAGR of 2.50% from 2023 to 2030, to $71.08 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Teva, Takeda, Jiangsu Hengrui Medicine Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and Jazz Pharmaceuticals among others.
China Dental Implant Market was valued at $401.10 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $848.70 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, and technological advancements. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The China Head and Neck Cancer Therapeutics Market was valued at $31.72 Mn in 2023 and is predicted to grow at a CAGR of 10.50% from 2023 to 2030, to $63.81 Mn by 2030. The key drivers of this industry include an aging population, advancement in treatment, and growth in the healthcare sector. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
The China PET Scan Market was valued at $155.9 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $248.8 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the China PET Scan Market are GE Healthcare, Siemens Healthineers, Basda Medical, Toshiba, Schiller, and Hitachi, among others.